Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	94	98	66	67	104	144
Market Cap Growth	52.12%	48.65%	-1.17%	-35.77%	-27.72%	56.56%
Enterprise Value	90	101	69	64	105	143
Last Close Price	6.84	7.15	4.85	4.92	7.68	10.73
PE Ratio	32.06	20.85	-	-	189.51	396.90
Forward PE	45.60	119.17	-	-	42.95	77.31
PS Ratio	1.65	1.72	1.32	1.24	2.12	3.50
PB Ratio	26.89	25.98	-34.65	14.39	11.42	19.34
P/TBV Ratio	29.72	28.51	-	15.51	11.85	20.26
P/FCF Ratio	13.03	14.01	-	60.64	25.25	-
P/OCF Ratio	12.29	13.27	-	16.80	15.99	-
PEG Ratio	-	-	-	-	2.86	5.44
EV/Sales Ratio	1.58	1.78	1.38	1.19	2.13	3.48
EV/EBITDA Ratio	19.72	15.65	-	-	46.90	92.05
EV/EBIT Ratio	29.87	20.94	-	-	172.63	389.82
EV/FCF Ratio	12.42	14.51	-	58.12	25.48	-
Debt / Equity Ratio	1.68	1.68	-3.90	1.86	1.04	1.29
Debt / EBITDA Ratio	0.93	0.76	-	-	2.29	3.37
Debt / FCF Ratio	0.82	0.90	-	7.82	2.30	-
Asset Turnover	2.05	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.87	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.93	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	182.28%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	6.78%	10.36%	-14.31%	-7.98%	1.21%	0.95%
Return on Capital (ROIC)	23.16%	38.77%	-46.11%	-17.49%	2.13%	1.76%
Return on Capital Employed (ROCE)	38.40%	57.10%	-	-	3.40%	2.20%
Earnings Yield	3.13%	4.80%	-11.04%	-8.00%	0.53%	0.25%
FCF Yield	7.68%	7.14%	-10.58%	1.65%	3.96%	-3.45%
Buyback Yield / Dilution	-4.67%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q